B. Braun Peripheral Nerve Block Devices Approved for Separate Medicare Payment Under the NOPAIN Act

RegulatoryapprovedStimuplex® Single-Shot Nerve Block NeedlesPositive

AI Analysis

Summary

B. Braun Medical's Stimuplex® Single-Shot Nerve Block Needles received CMS approval as a qualifying non-opioid medical device under the NOPAIN Act, enabling separate Medicare payment. This regulatory approval supports the company's non-opioid pain management device portfolio.

Outcome Details

Approved by CMS as qualifying non-opioid medical device under the NOPAIN Act for separate Medicare payment

Importance:5/10

Sentiment:

0.70

medical_deviceregulatory_approvalCMSnon-opioidnerve_blockNOPAIN_Act

Related Companies

$MDCE

Read the original article

Published by PR Newswire Pharma on October 14, 2026 1:07 PM

Read Original